Global Pharmaceutical Primary Packaging Lable Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Packaging
Publisher : MRA | Format : PDF
Global Pharmaceutical Primary Packaging Lable Market Research Report 2024
The term "Pharmaceutical primary packaging label" refers to all printed information on any over-the-counter drug or prescription drug primary packaging. Drug labeling is a highly standardized process, which plays an important role in promoting product approval and maintaining data quality and safety. Each label leaflet contains important product information, such as brand / drug name, manufacturer's name and address, batch number / batch number, product description details, active and inactive ingredients, indications, safety information, instructions for use, storage conditions and expiration date.
According to MRAResearch’s new survey, global Pharmaceutical Primary Packaging Lable market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Primary Packaging Lable market research.
Key manufacturers engaged in the Pharmaceutical Primary Packaging Lable industry include Avery Dennison Corporation, CCL Industries, Consolidated Label, Essentra, Herma, Lintec Corporation, MCC Label, ProMach and UPM, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pharmaceutical Primary Packaging Lable were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical Primary Packaging Lable market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Primary Packaging Lable market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Avery Dennison Corporation
CCL Industries
Consolidated Label
Essentra
Herma
Lintec Corporation
MCC Label
ProMach
UPM
Segment by Type
Solvent Acrylic
Hotmelt Rubber
Water Base Emulsion Acrylic
UV Curable
Prescription Primary Container
OTC Primary Container
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Pharmaceutical Primary Packaging Lable report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to MRAResearch’s new survey, global Pharmaceutical Primary Packaging Lable market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Primary Packaging Lable market research.
Key manufacturers engaged in the Pharmaceutical Primary Packaging Lable industry include Avery Dennison Corporation, CCL Industries, Consolidated Label, Essentra, Herma, Lintec Corporation, MCC Label, ProMach and UPM, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pharmaceutical Primary Packaging Lable were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical Primary Packaging Lable market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Primary Packaging Lable market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Avery Dennison Corporation
CCL Industries
Consolidated Label
Essentra
Herma
Lintec Corporation
MCC Label
ProMach
UPM
Segment by Type
Solvent Acrylic
Hotmelt Rubber
Water Base Emulsion Acrylic
UV Curable
Segment by Application
Prescription Primary Container
OTC Primary Container
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Pharmaceutical Primary Packaging Lable report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source